tiprankstipranks
Trending News
More News >
Jenscare Scientific Co. Ltd. Class H (HK:9877)
:9877
Hong Kong Market
Advertisement

Jenscare Scientific Co. Ltd. Class H (9877) Price & Analysis

Compare
1 Followers

9877 Stock Chart & Stats


Financials

9877 FAQ

What was Jenscare Scientific Co. Ltd. Class H’s price range in the past 12 months?
Jenscare Scientific Co. Ltd. Class H lowest stock price was HK$1.40 and its highest was HK$9.88 in the past 12 months.
    What is Jenscare Scientific Co. Ltd. Class H’s market cap?
    Jenscare Scientific Co. Ltd. Class H’s market cap is HK$4.81B.
      When is Jenscare Scientific Co. Ltd. Class H’s upcoming earnings report date?
      Jenscare Scientific Co. Ltd. Class H’s upcoming earnings report date is Sep 02, 2025 which is in 46 days.
        How were Jenscare Scientific Co. Ltd. Class H’s earnings last quarter?
        Currently, no data Available
        Is Jenscare Scientific Co. Ltd. Class H overvalued?
        According to Wall Street analysts Jenscare Scientific Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Jenscare Scientific Co. Ltd. Class H pay dividends?
          Jenscare Scientific Co. Ltd. Class H does not currently pay dividends.
          What is Jenscare Scientific Co. Ltd. Class H’s EPS estimate?
          Jenscare Scientific Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Jenscare Scientific Co. Ltd. Class H have?
          Jenscare Scientific Co. Ltd. Class H has 310,306,200 shares outstanding.
            What happened to Jenscare Scientific Co. Ltd. Class H’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Jenscare Scientific Co. Ltd. Class H?
            Currently, no hedge funds are holding shares in HK:9877

            Jenscare Scientific Co. Ltd. Class H Stock Smart Score

            9
            Outperform
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            130.27%
            12-Months-Change

            Fundamentals

            Return on Equity
            -16.39%
            Trailing 12-Months
            Asset Growth
            -25.16%
            Trailing 12-Months

            Company Description

            Jenscare Scientific Co. Ltd. Class H

            Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of invasive interventional therapies for structural heart diseases in the People's Republic of China. The company offers LuX-Valve, a transcatheter tricuspid valve replacement (TTVR) product candidate for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. Its products have applications in the treatment of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, and heart failure. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China.
            Similar Stocks
            Company
            Price & Change
            Follow
            Jacobio Pharmaceuticals Group Co., Ltd.
            China Isotope & Radiation Corp.
            Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
            CStone Pharmaceuticals
            China Shineway Pharmaceutical Group Limited
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis